BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15382072)

  • 1. Perineal talc exposure and epithelial ovarian cancer risk in the Central Valley of California.
    Mills PK; Riordan DG; Cress RD; Young HA
    Int J Cancer; 2004 Nov; 112(3):458-64. PubMed ID: 15382072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Weiderpass E; Persson IR
    J Natl Cancer Inst; 2002 Apr; 94(7):497-504. PubMed ID: 11929950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perineal exposure to talc and ovarian cancer risk.
    Harlow BL; Cramer DW; Bell DA; Welch WR
    Obstet Gynecol; 1992 Jul; 80(1):19-26. PubMed ID: 1603491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perineal Talc Use and Ovarian Cancer: A Systematic Review and Meta-Analysis.
    Penninkilampi R; Eslick GD
    Epidemiology; 2018 Jan; 29(1):41-49. PubMed ID: 28863045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perineal talc exposure and subsequent epithelial ovarian cancer: a case-control study.
    Wong C; Hempling RE; Piver MS; Natarajan N; Mettlin CJ
    Obstet Gynecol; 1999 Mar; 93(3):372-6. PubMed ID: 10074982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer.
    Merritt MA; Green AC; Nagle CM; Webb PM; ;
    Int J Cancer; 2008 Jan; 122(1):170-6. PubMed ID: 17721999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association Between Talc Use and Ovarian Cancer: A Retrospective Case-Control Study in Two US States.
    Cramer DW; Vitonis AF; Terry KL; Welch WR; Titus LJ
    Epidemiology; 2016 May; 27(3):334-46. PubMed ID: 26689397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and risk of epithelial ovarian cancer.
    Purdie DM; Bain CJ; Siskind V; Russell P; Hacker NF; Ward BG; Quinn MA; Green AC
    Br J Cancer; 1999 Oct; 81(3):559-63. PubMed ID: 10507786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perineal application of cosmetic talc and risk of invasive epithelial ovarian cancer: a meta-analysis of 11,933 subjects from sixteen observational studies.
    Huncharek M; Geschwind JF; Kupelnick B
    Anticancer Res; 2003; 23(2C):1955-60. PubMed ID: 12820486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of talc use and ovarian cancer.
    Gertig DM; Hunter DJ; Cramer DW; Colditz GA; Speizer FE; Willett WC; Hankinson SE
    J Natl Cancer Inst; 2000 Feb; 92(3):249-52. PubMed ID: 10655442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perineal talc use and ovarian cancer risk: a case study of scientific standards in environmental epidemiology.
    Huncharek M; Muscat J
    Eur J Cancer Prev; 2011 Nov; 20(6):501-7. PubMed ID: 21712717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial ovarian cancer risk by invasiveness and cell type in the Central Valley of California.
    Mills PK; Riordan DG; Cress RD
    Gynecol Oncol; 2004 Oct; 95(1):215-25. PubMed ID: 15385135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.
    Wenham RM; Schildkraut JM; McLean K; Calingaert B; Bentley RC; Marks J; Berchuck A
    Clin Cancer Res; 2003 Oct; 9(12):4396-403. PubMed ID: 14555511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of talcum powder and endometrial cancer risk.
    Neill AS; Nagle CM; Spurdle AB; Webb PM
    Cancer Causes Control; 2012 Mar; 23(3):513-9. PubMed ID: 22245995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perineal talc exposure and risk of ovarian carcinoma.
    Chang S; Risch HA
    Cancer; 1997 Jun; 79(12):2396-401. PubMed ID: 9191529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of perineal talc exposure and risk of ovarian cancer.
    Harlow BL; Hartge PA
    Regul Toxicol Pharmacol; 1995 Apr; 21(2):254-60. PubMed ID: 7644715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose aspirin use and the risk of ovarian cancer in Denmark.
    Baandrup L; Kjaer SK; Olsen JH; Dehlendorff C; Friis S
    Ann Oncol; 2015 Apr; 26(4):787-792. PubMed ID: 25538177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen replacement therapy and risk of epithelial ovarian cancer.
    Risch HA
    Gynecol Oncol; 1996 Nov; 63(2):254-7. PubMed ID: 8910636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perineal powder use and risk of ovarian cancer.
    Houghton SC; Reeves KW; Hankinson SE; Crawford L; Lane D; Wactawski-Wende J; Thomson CA; Ockene JK; Sturgeon SR
    J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25214560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Migration of Talc From the Perineum to Multiple Pelvic Organ Sites.
    McDonald SA; Fan Y; Welch WR; Cramer DW; Godleski JJ
    Am J Clin Pathol; 2019 Oct; 152(5):590-607. PubMed ID: 31305893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.